C
2021
In Vitro Characterization of Sumoylation of HR Proteins
ALTMANNOVÁ, Veronika and Lumír KREJČÍ
Basic information
Original name
In Vitro Characterization of Sumoylation of HR Proteins
Authors
ALTMANNOVÁ, Veronika (203 Czech Republic, guarantor, belonging to the institution) and
Lumír KREJČÍ (203 Czech Republic, belonging to the institution)
Edition
TOTOWA, Homologous Recombination: Methods and Protocols, p. 483-502, 20 pp. Methods in Molecular Biology, volume 2153, 2021
Publisher
HUMANA PRESS INC
Other information
Type of outcome
Kapitola resp. kapitoly v odborné knize
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Publication form
electronic version available online
RIV identification code
RIV/00216224:14110/21:00119654
Organization unit
Faculty of Medicine
Keywords in English
SUMO; Homologous recombination
Tags
International impact, Reviewed
V originále
In vitro analysis of posttranslational modifications such as sumoylation provides a great tool to not only identify the target proteins but also to characterize the specific effects of this modification on the protein features and uncover possible regulatory mechanism. In this chapter, we will describe the purification of yeast SUMO machinery proteins and their use to identify SUMO modification of target proteins in vitro. Furthermore, we will show several examples characterizing the effect of sumoylation on the biochemical activities of various proteins involved in homologous recombination (HR) that helped to better understand the regulatory role of this modification.
Links
EF16_025/0007381, research and development project | Name: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou |
|
GA17-17720S, research and development project | Name: Vnitřní vlastnosti RAD51 vlákna a jeho biologické regulace | Investor: Czech Science Foundation |
|
206292/E/17/Z, interní kód MU | Name: Mechanics and execution of homologous recombination - biophysics to the organism | Investor: Wellcome Trust |
|
Displayed: 11/11/2024 04:50